DICE Therapeutics, Inc. - FORM S-1 - EX-23.1 - August 25, 2021

Attached files

file filename
S-1 - S-1 - DICE Therapeutics, Inc.d134346ds1.htm
EX-21.1 - EX-21.1 - DICE Therapeutics, Inc.d134346dex211.htm
EX-10.10 - EX-10.10 - DICE Therapeutics, Inc.d134346dex1010.htm
EX-10.9 - EX-10.9 - DICE Therapeutics, Inc.d134346dex109.htm
EX-10.8 - EX-10.8 - DICE Therapeutics, Inc.d134346dex108.htm
EX-10.7 - EX-10.7 - DICE Therapeutics, Inc.d134346dex107.htm
EX-10.6 - EX-10.6 - DICE Therapeutics, Inc.d134346dex106.htm
EX-10.5 - EX-10.5 - DICE Therapeutics, Inc.d134346dex105.htm
EX-10.2 - EX-10.2 - DICE Therapeutics, Inc.d134346dex102.htm
EX-10.1 - EX-10.1 - DICE Therapeutics, Inc.d134346dex101.htm
EX-4.4 - EX-4.4 - DICE Therapeutics, Inc.d134346dex44.htm
EX-4.3 - EX-4.3 - DICE Therapeutics, Inc.d134346dex43.htm
EX-4.1 - EX-4.1 - DICE Therapeutics, Inc.d134346dex41.htm
EX-3.5 - EX-3.5 - DICE Therapeutics, Inc.d134346dex35.htm
EX-3.4 - EX-3.4 - DICE Therapeutics, Inc.d134346dex34.htm
EX-3.3 - EX-3.3 - DICE Therapeutics, Inc.d134346dex33.htm
EX-2.1 - EX-2.1 - DICE Therapeutics, Inc.d134346dex21.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated July 2, 2021, in the Registration Statement on Form S-1 and related Prospectus of DiCE Molecules Holdings, LLC for the registration of shares of its common stock.

 

/s/ Ernst & Young LLP
San Jose, California
August 25, 2021